Medasense Biometrics
2016: Investments
In May, 2016 Medasense Biometrics announced completion of the transaction on the investment attraction in which the Baxter Ventures fund belonging to pharmaceutical company Baxter International took part. The volume of investments in the Israeli startup does not reveal.
 | We are glad to participation of Baxter Ventures in this round — the CEO and the founder of Medasense Galit Zuckerman says. — This financing confirms our aspiration to improve care of patients, helping doctors with personalisation and optimization of treatment of pain. |  |
The managing director of Baxter Ventures Anne Sissel says that the innovation approach of Medasense to development of technologies of objective assessment of pain and strong team of heads made this company attractive to investments.
| | The possibility of more effective management of use of analgetics and maintenance of haemo dynamic parameters at the stable level have direct advantages, helping to accelerate time of rehabilitation and to improve clinical results — Sissel notes. | |
In March, 2016 Medasense attracted $8 million from group of investors which entered Benslie International company, the unnamed developer of world-class medical technologies and several private investors.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |